Illumina, Inc.
ILMN
Classifica tra le azioni
#603
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis... Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
Prezzo delle azioni
$268.04
Capitalizzazione di mercato
$40.47B
Variazione (1 giorno)
2.05%
Variazione (1 anno)
169.39%
Paese
US
Scambia Illumina, Inc. (ILMN)
Categoria
Healthcare
Ricavi di Illumina, Inc. (ILMN)
Ricavi nel Jun 2026 TTM: $4.49B
Secondo gli ultimi rapporti finanziari di Illumina, Inc., i ricavi attuali dell'azienda (TTM) sono pari a $4.49B. Nel 2024, l'azienda ha registrato ricavi di $4.37B una diminuzione rispetto a i ricavi dell'anno 2023, che erano pari a $4.50B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Illumina, Inc. da 2000 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $4.49B | 3.48% |
| 2025 | $4.34B | -0.69% |
| 2024 | $4.37B | -2.93% |
| 2023 | $4.50B | -0.49% |
| 2022 | $4.53B | 39.73% |
| 2021 | $3.24B | -8.58% |
| 2019 | $3.54B | 6.30% |
| 2018 | $3.33B | 21.11% |
| 2017 | $2.75B | 14.74% |
| 2016 | $2.40B | 8.05% |
| 2015 | $2.22B | 19.25% |
| 2014 | $1.86B | 30.97% |
| 2013 | $1.42B | 23.74% |
| 2012 | $1.15B | 8.81% |
| 2011 | $1.06B | 16.93% |
| 2010 | $902.74M | 35.48% |
| 2009 | $666.32M | 16.24% |
| 2008 | $573.23M | 56.28% |
| 2007 | $366.80M | 98.71% |
| 2006 | $184.59M | 151.13% |
| 2005 | $73.50M | 45.31% |
| 2004 | $50.58M | 80.43% |
| 2003 | $28.04M | 179.23% |
| 2002 | $10.04M | 303.86% |
| 2001 | $2.49M | 89.90% |
| 2000 | $1.31M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $46.34B | 931.29% |
US
|
|
| $25.11B | 458.80% |
US
|
|
| $2.71B | -39.75% |
US
|
|
| - | - |
CN
|
|
| $7.37B | 64.08% |
US
|
